Allergies are exacerbated reactions of the immune system to certain allergens, agents external to the body capable of causing hypersensitivity reactions when in contact with the immune system of susceptible individuals. Want to know more about these conditions and which molecules RC REDOL markets internationally for them? Read the article below and find out everything!
As we mentioned allergies are reactions to allergens, but which ones are the most common? Some common types of allergies are to foods, like peanuts, to medicines, like penicillin, to insect stings, for example, bees or wasps, and also to synthetic materials like rubber or latex and some metals. Although these are common elements of everyday life, these reactions are chronic diseases, making it difficult for patients to lead a normal life and, if left undetected and exposure to allergens is continuous, can be extremely dangerous.
Typically, their symptoms affect the respiratory tract, eyes, or skin. Nasal discharge and obstruction, coughing, sneezing or even shortness of breath can occur when allergies affect the respiratory tract. In the eyes, the most common symptoms are itching, red or watery eyes, and in the skin, itching, but also swelling, spots, and redness.
Allergic diseases have a genetic component, so a family tendency is a risk factor for their development. Other risk factors are a sedentary lifestyle, diet, obesity, environmental and domestic pollution, and smoking. Allergies can also originate from exposure to allergens and the non-responsible use of medicines, namely antibiotics.
It should be stressed that, apart from genetic predisposition, all risk factors can be minimized through lifestyle changes. Allergic crisis prevention is therefore the first step, which after all is a fundamental non-pharmacological measure for maintaining patients’ quality of life. There are also pharmacological therapies, such as antihistamines and anti-inflammatories, and immunotherapy with allergens, which can have positive results and help to control the disease.
Within the pharmacological treatment options, RC REDOL internationally commercializes several molecules, which can be introduced into your market. We are talking about mometasone, hydrocortisone, the combination of betamethasone and salicylic acid, diphenhydramine and its combination of zinc oxide and camphor, but also oxymetazoline, flurbiprofen sodium, ketorolac tromethamine, ketotifen, and prednisolone acetate. We also market dexamethasone, cetirizine, desloratadine, ebastine, levocetirizine, loratadine, and rupatadine.
These medicines are manufactured in Europe according to good manufacturing practices and European standards. Moreover, you can take advantage of our knowledge and experience in introducing drugs in international markets and market these products in your country. Contact RC REDOL commercial team and find out how to do it.
RC REDOL, building connections!